EGFR and familial pancreatic carcinoma: The unilateral inhibition of the EGFR family may exist the above drawbacks in the treatment of pancreatic cancer.43, 44 Partially due to that, many therapeutic agents to block EGFR relevant pathways had little effect on PDAC.